Antiarrhythmic drugs can cause new, potentially deadly heart arrhythmias. Amiodarone is effective but can cause serious side effects and requires careful monitoring. Multaq cannot be used in people ...

A new editorial synthesizes recent evidence on managing cardiac arrhythmias in critically ill patients, highlighting ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is unclear.

AFNET, the German Competence Network on Atrial Fibrillation, therefore performed a randomized clinical trial to investigate whether a short-term antiarrhythmic drug treatment for the duration of four ...

Researchers found that 56 and 30% of the patients in the pulsed field ablation and antiarrhythmic-drug groups, respectively, had treatment success at 12 months. HealthDay News — For patients with ...

Upfront catheter ablation is a better first-line strategy for patients who develop ventricular tachycardia (VT) after a myocardial infarction (MI) than waiting until antiarrhythmic drugs fail, a ...

Pulsed field ablation (PFA) proved a better first-line treatment for persistent atrial fibrillation (AF) than did antiarrhythmic drug therapy, with less recurrence and similar adverse event risk, the ...

A new, multicenter study demonstrated that ablation treatment may be a better first option than medication for many heart attack survivors who develop abnormal electrical short circuits in their heart ...

Tasigna (nilotinib) is a brand-name oral capsule prescribed for a certain type of chronic myeloid leukemia (CML). Tasigna can interact with some other drugs, such as certain antiarrhythmic medications ...